1. Home
  2. MYSZ vs AZTR Comparison

MYSZ vs AZTR Comparison

Compare MYSZ & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.76

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.28

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
AZTR
Founded
1999
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.2M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
MYSZ
AZTR
Price
$0.76
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
84.5K
315.9K
Earning Date
11-14-2025
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,512,000.00
N/A
Revenue This Year
$29.71
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.26
52 Week High
$4.63
$4.33

Technical Indicators

Market Signals
Indicator
MYSZ
AZTR
Relative Strength Index (RSI) 39.21 36.30
Support Level $0.75 $0.27
Resistance Level $0.86 $0.33
Average True Range (ATR) 0.05 0.03
MACD -0.00 0.00
Stochastic Oscillator 27.07 14.52

Price Performance

Historical Comparison
MYSZ
AZTR

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: